Results 241 to 250 of about 8,509,826 (346)

An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial

open access: yesCancer Communications, EarlyView.
Abstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with locally advanced, recurrent or metastatic, hormone ...
Jiayu Wang   +18 more
wiley   +1 more source

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate [PDF]

open access: bronze, 2007
Michael Schiff   +12 more
openalex   +1 more source

Medical practice and placebo response: an inseparable bond? [PDF]

open access: yesWien Klin Wochenschr, 2020
Jilch S, Sel R, Shariat SF.
europepmc   +1 more source

Revelation of a personal placebo response: Its effects on mood, attitudes and future placebo responding [PDF]

open access: green, 2007
Karen S. Chung   +3 more
openalex   +1 more source

Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor

open access: yesCancer Communications, EarlyView.
Abstract Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their ...
Wenpeng Cai   +6 more
wiley   +1 more source

Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta-regression analysis to develop an enrichment strategy. [PDF]

open access: yesAlcohol Clin Exp Res, 2021
Scherrer B   +26 more
europepmc   +1 more source

1557: Relationship between Screening IPSS and the Placebo Run-In Response in the Pooled Reduce and Combat Population [PDF]

open access: bronze, 2007
Claus G. Roehrborn   +4 more
openalex   +1 more source

Citrus Flavonoids as Antimicrobials

open access: yesChemistry &Biodiversity, EarlyView.
Citrus flavonoids are powerful and versatile antimicrobials whose mechanism of action often involves disruption of the bacterial membrane, thereby minimizing antimicrobial resistance. This study provides a unified perspective. ABSTRACT Citrus flavonoids are highly bioactive compounds exerting numerous health benefits including anticancer, antioxidant ...
Rosaria Ciriminna   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy